Health News

Vitamins for Old Eyes, But Not Omega-3s
As people age, their eyesight can worsen. Millions get a condition that can lead to blindness. A vitamin regimen can help, but adding supplements provides no extra benefit.
Cataract Risk Unchanged by Supplements
The body can use different types of antioxidants and omega-3 fatty acids to promote good health. But supplements may not be able to keep vision clear from cataract cloudiness later in life.
A Recess for the Eyes
A lot of kids look forward to recess during school. While spending more time in the great outdoors can allow kids to release that extra energy and give their brains a break, it might also help keep their vision strong and healthy.
Looking at Eye Cancer in Kids
Cancer of the eye is very rare. It strikes mostly infants and young children—about 350 kids a year in the US. The disease is curable when caught and treated early. If the cancer spreads, though, the outlook is not as good.
RA Rx for Dry Eye Solution
Dry eye disease isn’t just uncomfortable; in some cases the lack of moisture can lead to real damage and trouble seeing clearly. A new kind of eye drop may be on the way to help improve symptoms.
Alcon announces FDA approval of Simbrinza Suspension
Alcon, the global leader in eye care and a division of Novartis, announces US FDA approval for Simbrinza(TM) Suspension, indicated for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension. Elevated IOP is the only modifiable risk factor for glaucoma. Glaucoma is a group of eye diseases that lead to progressive damage of the optic nerve and can result in gradual, irreversible loss of vision, and eventually blindness, if left untreated. Glaucoma affects more than 2.2 million Americans and is the second-leading cause of...
Bausch + Lomb Receives FDA Approval for PROLENSA
Bausch + Lomb, a global eye health company, today announced that the US Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for PROLENSA™ (bromfenac ophthalmic solution) 0.07 percent prescription eye drop.
Avastin Unit Dose Syringes by Clinical Specialties Voluntarily Recalled
Clinical Specialties is voluntarily recalling Avastin unit dose syringes. The product has or potentially could result in an infection within the eye. Clinical Specialties has received reports of five intraocular infections from physician’s offices and this is how the problem was identified.
Losing Sight & Feeling Hopeless
Partial vision loss can impact many daily activities. Coping with losing the ability to drive or read can take an emotional toll that may need treatment.
A Better Outlook For Cancer Babies
A genetic discovery has given some babies a new life – literally. The finding actually redefines a rare but curable cancer that’s usually spotted in infants or toddlers.